483 Novartis Pharma AG Oct 2000

483 Novartis Pharma AG Oct 2000

Jose Cruz Gonzalez FDA$119.00 - Available Now

FDA investigators audited the Novartis Pharma AG - Basel, Switzerland facility and issued inspectional observations (via FDA 483) on 30 Oct 2000.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Oct 2000
  • Location: Basel, Switzerland
  • FEI: 3002807772
Add To Cart